Insider filing · HCWB

Scott T Garrett bought $250K of HCW Biologics (HCWB)

Executed May 22, disclosed May 27, 5 days later.

Over the 21 trading sessions from the disclosed entry session (May 27), the stock returned -57.6% (delay-adjusted); from the execution session (May 22), -66.4%. Derived: entry at the session's open, exit at the close 20 sessions later.

SG Scott T Garrett Director profile →

Scott T Garrett (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in HCW Biologics Inc. (HCWB). Across 1 priced purchase filing, the average 21-session return was -66.4% from execution and -57.6% from disclosure (delay-adjusted; derived). The largest single filing was $250K of HCWB (177,936 sh × $1.41, as filed), executed May 22.

HCWB HCW Biologics Inc. HCWB · Healthcare · 6 filings in 24 months ticker →

Healthcare · HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, lo…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→